Stock Analysis on Net

DexCom Inc. (NASDAQ:DXCM)

This company has been moved to the archive! The financial data has not been updated since October 26, 2023.

Analysis of Short-term (Operating) Activity Ratios
Quarterly Data

Microsoft Excel

Short-term Activity Ratios (Summary)

DexCom Inc., short-term (operating) activity ratios (quarterly data)

Microsoft Excel
Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018
Turnover Ratios
Inventory turnover 2.47 2.74 2.94 3.35 3.15 2.67 2.45 2.15 2.03 2.10 2.28 2.76 3.14 3.75 4.10 4.55 4.20 3.86 4.09 5.20
Receivables turnover 4.33 4.26 4.75 4.08 4.95 4.77 4.72 4.76 4.38 4.49 4.57 4.50 4.92 5.79 5.32 5.16 5.75 5.62 5.51 4.55
Working capital turnover 1.13 1.09 1.59 1.59 1.12 0.89 0.85 0.83 0.79 0.76 0.71 0.69 0.67 0.65 0.97 0.92 0.90 0.84 0.77 0.70
Average No. Days
Average inventory processing period 148 133 124 109 116 137 149 170 180 174 160 132 116 97 89 80 87 95 89 70
Add: Average receivable collection period 84 86 77 89 74 77 77 77 83 81 80 81 74 63 69 71 63 65 66 80
Operating cycle 232 219 201 198 190 214 226 247 263 255 240 213 190 160 158 151 150 160 155 150

Based on: 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31).

Short-term activity ratio Description The company
Inventory turnover An activity ratio calculated as cost of goods sold divided by inventory. DexCom Inc. inventory turnover ratio deteriorated from Q1 2023 to Q2 2023 and from Q2 2023 to Q3 2023.
Receivables turnover An activity ratio equal to revenue divided by receivables. DexCom Inc. receivables turnover ratio deteriorated from Q1 2023 to Q2 2023 but then slightly improved from Q2 2023 to Q3 2023.
Working capital turnover An activity ratio calculated as revenue divided by working capital. DexCom Inc. working capital turnover ratio deteriorated from Q1 2023 to Q2 2023 but then slightly improved from Q2 2023 to Q3 2023.

Short-term activity ratio Description The company
Average inventory processing period An activity ratio equal to the number of days in the period divided by inventory turnover over the period. DexCom Inc. number of days of inventory outstanding deteriorated from Q1 2023 to Q2 2023 and from Q2 2023 to Q3 2023.
Average receivable collection period An activity ratio equal to the number of days in the period divided by receivables turnover. DexCom Inc. number of days of receivables outstanding deteriorated from Q1 2023 to Q2 2023 but then slightly improved from Q2 2023 to Q3 2023.
Operating cycle Equal to average inventory processing period plus average receivables collection period. DexCom Inc. operating cycle deteriorated from Q1 2023 to Q2 2023 and from Q2 2023 to Q3 2023.

Inventory Turnover

DexCom Inc., inventory turnover calculation (quarterly data)

Microsoft Excel
Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018
Selected Financial Data (US$ in thousands)
Cost of sales 351,700 324,900 278,900 273,900 275,400 246,700 230,700 225,600 203,300 178,000 161,100 169,800 160,500 167,700 148,600 153,500 149,400 129,900 111,700 115,200 98,100 88,900 65,500
Inventory 498,600 421,100 366,000 306,700 311,000 339,500 342,200 357,300 351,300 319,300 289,700 234,700 200,700 165,300 141,900 119,800 120,400 117,900 101,100 70,700 55,200 46,200 51,600
Short-term Activity Ratio
Inventory turnover1 2.47 2.74 2.94 3.35 3.15 2.67 2.45 2.15 2.03 2.10 2.28 2.76 3.14 3.75 4.10 4.55 4.20 3.86 4.09 5.20
Benchmarks
Inventory Turnover, Competitors2
Abbott Laboratories 2.71 2.62 2.77 3.10 3.37 3.24 3.36 3.59 3.47 3.27 2.99 2.99 2.71 2.56 2.92 3.07
Cigna Group 29.58 28.53 30.04 26.13 30.87 32.34 34.32 31.58 37.54 36.13 36.50 32.70 37.84 36.30 38.13 36.70
CVS Health Corp. 16.34 16.48 15.15 14.05 14.46 14.64 13.60 13.52 13.49 13.48 12.57 11.88 12.43 13.03 12.68 12.06
Intuitive Surgical Inc. 1.99 2.21 2.25 2.27 2.36 2.62 2.82 2.98 2.90 2.84 2.64 2.49 2.18 2.22 2.30 2.30
Medtronic PLC 1.92 2.00 2.09 2.20 2.26 2.38 2.47 2.43 2.24 2.20 2.10 2.23 2.34 2.35 2.37 2.44

Based on: 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31).

1 Q3 2023 Calculation
Inventory turnover = (Cost of salesQ3 2023 + Cost of salesQ2 2023 + Cost of salesQ1 2023 + Cost of salesQ4 2022) ÷ Inventory
= (351,700 + 324,900 + 278,900 + 273,900) ÷ 498,600 = 2.47

2 Click competitor name to see calculations.

Short-term activity ratio Description The company
Inventory turnover An activity ratio calculated as cost of goods sold divided by inventory. DexCom Inc. inventory turnover ratio deteriorated from Q1 2023 to Q2 2023 and from Q2 2023 to Q3 2023.

Receivables Turnover

DexCom Inc., receivables turnover calculation (quarterly data)

Microsoft Excel
Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018
Selected Financial Data (US$ in thousands)
Revenue 975,000 871,300 741,500 815,200 769,600 696,200 628,800 698,200 650,200 595,100 505,000 568,900 500,900 451,800 405,100 462,800 396,300 336,400 280,500 338,000 266,700 242,500 184,400
Accounts receivable, net 785,700 750,600 636,800 713,300 564,100 560,800 544,500 514,300 529,100 483,500 443,400 428,500 370,000 296,500 300,700 286,300 234,900 217,300 204,700 226,700 169,800 162,000 123,900
Short-term Activity Ratio
Receivables turnover1 4.33 4.26 4.75 4.08 4.95 4.77 4.72 4.76 4.38 4.49 4.57 4.50 4.92 5.79 5.32 5.16 5.75 5.62 5.51 4.55
Benchmarks
Receivables Turnover, Competitors2
Abbott Laboratories 6.15 6.52 6.89 7.02 7.03 6.33 6.20 6.64 6.61 6.58 6.13 5.40 5.70 6.12 6.06 5.88
CVS Health Corp. 10.53 11.44 11.65 11.79 11.94 11.27 11.30 11.91 11.23 11.48 11.32 12.32 11.14 11.68 11.33 13.04
Elevance Health Inc. 17.93 18.82 16.53 18.81 19.51 18.80 16.67 20.66 18.93 18.81 17.39 19.72 18.91 18.04 16.74 18.20
Humana Inc. 55.60 68.53 30.60 55.25 56.74 26.54 27.18 45.69 42.91 32.51 35.43 66.78 64.58 31.30 33.43 60.97
Intuitive Surgical Inc. 7.12 7.37 6.95 6.60 7.20 7.11 6.52 7.30 7.90 7.38 6.96 6.75 7.32 8.56 8.73 6.94
Medtronic PLC 5.23 5.48 5.85 5.71 5.84 5.79 5.82 5.51 5.35 5.21 5.73 6.22 4.97 5.05 5.20 4.91
UnitedHealth Group Inc. 17.23 19.23 14.88 18.22 18.37 16.27 15.65 20.07 19.60 18.53 16.35 19.86 20.63 19.62 16.73 20.32

Based on: 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31).

1 Q3 2023 Calculation
Receivables turnover = (RevenueQ3 2023 + RevenueQ2 2023 + RevenueQ1 2023 + RevenueQ4 2022) ÷ Accounts receivable, net
= (975,000 + 871,300 + 741,500 + 815,200) ÷ 785,700 = 4.33

2 Click competitor name to see calculations.

Short-term activity ratio Description The company
Receivables turnover An activity ratio equal to revenue divided by receivables. DexCom Inc. receivables turnover ratio deteriorated from Q1 2023 to Q2 2023 but then slightly improved from Q2 2023 to Q3 2023.

Working Capital Turnover

DexCom Inc., working capital turnover calculation (quarterly data)

Microsoft Excel
Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018
Selected Financial Data (US$ in thousands)
Current assets 4,698,400 5,002,900 3,767,400 3,668,800 3,398,500 3,808,700 3,746,600 3,684,400 3,656,200 3,474,200 3,445,100 3,424,800 3,237,100 3,033,000 1,995,700 1,969,400 1,815,700 1,744,200 1,690,800 1,699,500 914,100 836,000 729,300
Less: Current liabilities 1,678,600 2,069,700 1,865,000 1,839,300 900,500 807,000 711,400 720,800 734,900 600,700 604,100 614,100 506,400 400,100 342,800 360,200 322,400 288,200 235,400 222,400 193,900 170,800 125,100
Working capital 3,019,800 2,933,200 1,902,400 1,829,500 2,498,000 3,001,700 3,035,200 2,963,600 2,921,300 2,873,500 2,841,000 2,810,700 2,730,700 2,632,900 1,652,900 1,609,200 1,493,300 1,456,000 1,455,400 1,477,100 720,200 665,200 604,200
 
Revenue 975,000 871,300 741,500 815,200 769,600 696,200 628,800 698,200 650,200 595,100 505,000 568,900 500,900 451,800 405,100 462,800 396,300 336,400 280,500 338,000 266,700 242,500 184,400
Short-term Activity Ratio
Working capital turnover1 1.13 1.09 1.59 1.59 1.12 0.89 0.85 0.83 0.79 0.76 0.71 0.69 0.67 0.65 0.97 0.92 0.90 0.84 0.77 0.70
Benchmarks
Working Capital Turnover, Competitors2
Abbott Laboratories 4.15 4.39 4.21 4.48 3.92 3.63 4.13 3.87 3.98 4.02 3.99 4.06 4.52 5.02 6.84 6.64
Cigna Group
CVS Health Corp.
Elevance Health Inc. 7.92 7.69 7.60 8.37 9.11 8.85 8.65 7.23 6.79 6.67 5.38 6.39 5.98 5.40 6.81 6.11
Humana Inc. 9.72 9.34 8.98 10.27 10.54 9.53 9.27 8.67 7.47 7.38 7.61 7.42 6.04 6.14 6.91 7.19
Intuitive Surgical Inc. 0.95 1.03 1.15 1.29 1.21 1.17 1.26 1.22 1.17 1.03 0.88 0.77 0.80 0.88 1.23 1.23
Medtronic PLC 2.81 2.82 3.84 2.97 2.21 2.13 2.15 2.15 2.02 2.00 2.44 2.48 2.03 2.13 2.16 2.26
UnitedHealth Group Inc.

Based on: 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31).

1 Q3 2023 Calculation
Working capital turnover = (RevenueQ3 2023 + RevenueQ2 2023 + RevenueQ1 2023 + RevenueQ4 2022) ÷ Working capital
= (975,000 + 871,300 + 741,500 + 815,200) ÷ 3,019,800 = 1.13

2 Click competitor name to see calculations.

Short-term activity ratio Description The company
Working capital turnover An activity ratio calculated as revenue divided by working capital. DexCom Inc. working capital turnover ratio deteriorated from Q1 2023 to Q2 2023 but then slightly improved from Q2 2023 to Q3 2023.

Average Inventory Processing Period

DexCom Inc., average inventory processing period calculation (quarterly data)

Microsoft Excel
Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018
Selected Financial Data
Inventory turnover 2.47 2.74 2.94 3.35 3.15 2.67 2.45 2.15 2.03 2.10 2.28 2.76 3.14 3.75 4.10 4.55 4.20 3.86 4.09 5.20
Short-term Activity Ratio (no. days)
Average inventory processing period1 148 133 124 109 116 137 149 170 180 174 160 132 116 97 89 80 87 95 89 70
Benchmarks (no. days)
Average Inventory Processing Period, Competitors2
Abbott Laboratories 135 139 132 118 108 113 109 102 105 111 122 122 135 142 125 119
Cigna Group 12 13 12 14 12 11 11 12 10 10 10 11 10 10 10 10
CVS Health Corp. 22 22 24 26 25 25 27 27 27 27 29 31 29 28 29 30
Intuitive Surgical Inc. 183 166 162 161 155 139 130 122 126 129 138 147 167 164 159 159
Medtronic PLC 190 183 174 166 161 153 148 150 163 166 174 164 156 155 154 150

Based on: 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31).

1 Q3 2023 Calculation
Average inventory processing period = 365 ÷ Inventory turnover
= 365 ÷ 2.47 = 148

2 Click competitor name to see calculations.

Short-term activity ratio Description The company
Average inventory processing period An activity ratio equal to the number of days in the period divided by inventory turnover over the period. DexCom Inc. number of days of inventory outstanding deteriorated from Q1 2023 to Q2 2023 and from Q2 2023 to Q3 2023.

Average Receivable Collection Period

DexCom Inc., average receivable collection period calculation (quarterly data)

Microsoft Excel
Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018
Selected Financial Data
Receivables turnover 4.33 4.26 4.75 4.08 4.95 4.77 4.72 4.76 4.38 4.49 4.57 4.50 4.92 5.79 5.32 5.16 5.75 5.62 5.51 4.55
Short-term Activity Ratio (no. days)
Average receivable collection period1 84 86 77 89 74 77 77 77 83 81 80 81 74 63 69 71 63 65 66 80
Benchmarks (no. days)
Average Receivable Collection Period, Competitors2
Abbott Laboratories 59 56 53 52 52 58 59 55 55 55 60 68 64 60 60 62
CVS Health Corp. 35 32 31 31 31 32 32 31 32 32 32 30 33 31 32 28
Elevance Health Inc. 20 19 22 19 19 19 22 18 19 19 21 19 19 20 22 20
Humana Inc. 7 5 12 7 6 14 13 8 9 11 10 5 6 12 11 6
Intuitive Surgical Inc. 51 50 53 55 51 51 56 50 46 49 52 54 50 43 42 53
Medtronic PLC 70 67 62 64 63 63 63 66 68 70 64 59 73 72 70 74
UnitedHealth Group Inc. 21 19 25 20 20 22 23 18 19 20 22 18 18 19 22 18

Based on: 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31).

1 Q3 2023 Calculation
Average receivable collection period = 365 ÷ Receivables turnover
= 365 ÷ 4.33 = 84

2 Click competitor name to see calculations.

Short-term activity ratio Description The company
Average receivable collection period An activity ratio equal to the number of days in the period divided by receivables turnover. DexCom Inc. number of days of receivables outstanding deteriorated from Q1 2023 to Q2 2023 but then slightly improved from Q2 2023 to Q3 2023.

Operating Cycle

DexCom Inc., operating cycle calculation (quarterly data)

No. days

Microsoft Excel
Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018
Selected Financial Data
Average inventory processing period 148 133 124 109 116 137 149 170 180 174 160 132 116 97 89 80 87 95 89 70
Average receivable collection period 84 86 77 89 74 77 77 77 83 81 80 81 74 63 69 71 63 65 66 80
Short-term Activity Ratio
Operating cycle1 232 219 201 198 190 214 226 247 263 255 240 213 190 160 158 151 150 160 155 150
Benchmarks
Operating Cycle, Competitors2
Abbott Laboratories 194 195 185 170 160 171 168 157 160 166 182 190 199 202 185 181
CVS Health Corp. 57 54 55 57 56 57 59 58 59 59 61 61 62 59 61 58
Intuitive Surgical Inc. 234 216 215 216 206 190 186 172 172 178 190 201 217 207 201 212
Medtronic PLC 260 250 236 230 224 216 211 216 231 236 238 223 229 227 224 224

Based on: 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31).

1 Q3 2023 Calculation
Operating cycle = Average inventory processing period + Average receivable collection period
= 148 + 84 = 232

2 Click competitor name to see calculations.

Short-term activity ratio Description The company
Operating cycle Equal to average inventory processing period plus average receivables collection period. DexCom Inc. operating cycle deteriorated from Q1 2023 to Q2 2023 and from Q2 2023 to Q3 2023.